ChronoScale extends $2M term loan to 2026

Rhea-AI Filing Summary

ChronoScale Holdings Corporation (CHRN) reports that its wholly owned subsidiary ChronoScale Intermediate, LLC, as borrower, and Ekso Bionics, Inc., as guarantor, entered into a First Amendment to their Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC.

The underlying term loan has an aggregate principal amount of up to $2.0 million, all of which was outstanding as of the amendment date. The amendment extends the loan’s time-based maturity to November 12, 2026 and specifies that a sale of the guarantor on the terms described in the amendment will be treated as a Permitted Disposition. All other material terms of the original agreement remain in effect.

8-K Event Classification

2 items: 1.01, 9.01

2 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Term Loan Principal: $2.0 million Outstanding Principal: $2.0 million Equity Proceeds Maturity Trigger: $2.4 million +2 more

5 metrics

Term Loan Principal $2.0 million Aggregate principal amount of term loan provided under the 2025 agreement

Outstanding Principal $2.0 million Principal outstanding as of the September 12, 2026 First Amendment

Equity Proceeds Maturity Trigger $2.4 million Net proceeds from sale of borrower equity interests that can trigger earlier maturity

Extended Maturity Date November 12, 2026 New time-based maturity date for the term loan after the First Amendment

Original Agreement Date September 12, 2025 Date of the original Secured Promissory Note and Security Agreement

Key Terms

Material Definitive Agreement, Secured Promissory Note and Security Agreement, Term Loan, Permitted Disposition, +1 more

5 terms

Material Definitive Agreement regulatory

"Item 1.01 Entry into a Material Definitive Agreement Effective as of September 12, 2026"

A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.

Secured Promissory Note and Security Agreement financial

"entered into the First Amendment to the Secured Promissory Note and Security Agreement"

Term Loan financial

"the Lender provided to the Borrower a term loan in an aggregate principal amount"

A term loan is a type of loan that is borrowed for a set period of time, with a fixed schedule for repaying the money, usually in regular payments. It matters to investors because it represents a company's borrowing costs and financial stability; reliable repayment of these loans can indicate strong financial health, while difficulties may signal potential risks.

Permitted Disposition financial

"shall constitute a Permitted Disposition (as defined therein)"

Guarantor financial

"Ekso Bionics, Inc., a Delaware corporation (the “Guarantor”)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What loan agreement did CHRN amend on September 12, 2026?

ChronoScale Holdings’ subsidiaries amended a Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC. The agreement originally dated September 12, 2025 provides a term loan of up to $2.0 million to ChronoScale Intermediate, LLC, guaranteed by Ekso Bionics, Inc.

How large is the term loan mentioned in ChronoScale Holdings (CHRN)’s 8-K?

The term loan under the Secured Promissory Note and Security Agreement is for an aggregate principal amount of up to $2.0 million. As of the First Amendment date, the entire $2.0 million principal amount was outstanding.

How did the First Amendment change the loan maturity for CHRN’s term loan?

The original agreement set maturity as the earlier of 12 months from September 12, 2025 or receipt of $2.4 million in specified equity proceeds. The First Amendment extends the time-based maturity date to November 12, 2026, while retaining the equity-proceeds trigger.

What is the significance of the Permitted Disposition in CHRN’s amended loan?

The First Amendment provides that a sale of the guarantor, Ekso Bionics, Inc., on the terms and conditions described in the amendment, will constitute a Permitted Disposition. This means such a sale is allowed under the loan agreement framework.

Which ChronoScale subsidiaries are parties to the amended loan agreement?

The loan parties are ChronoScale Intermediate, LLC (formerly Ekso Bionics Holdings, Inc. and ChronoScale Corporation) as the borrower and Ekso Bionics, Inc. as the guarantor. Both entities are wholly owned subsidiaries of ChronoScale Holdings Corporation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 05:05 PM Accepted by SEC EDGAR 09/16/2026 - 05:05 PM Learn about SEC filing dates

false 0001549084 0001549084 2026-09-12 2026-09-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

September 12, 2026

(Date of earliest event reported)

CHRONOSCALE HOLDINGS CORPORATION

(Exact name of registrant as specified in its charter)

Nevada		001-37854		42-3357005
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2440 Sand Hill Road, Suite 400 Menlo Park, CA		94025
(Address of principal executive offices)		(Zip Code)

214-427-1704

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		CHRN		Nasdaq Capital Market

Item 1.01 Entry into a Material Definitive Agreement

Effective as of September 12, 2026, ChronoScale Intermediate, LLC, a Nevada limited liability company (f/k/a Ekso Bionics Holdings, Inc. and ChronoScale Corporation, the “Borrower”) and Ekso Bionics, Inc., a Delaware corporation (the “Guarantor” and, together with the Borrower, the “Loan Parties”) entered into the First Amendment to the Secured Promissory Note and Security Agreement (the “First Amendment”) with B. Riley Commercial Capital, LLC (the “Lender”). Each of the Loan Parties is a wholly owned subsidiary of ChronoScale Holdings Corporation, a Nevada corporation (the “Company”). Pursuant to the terms of the Secured Promissory Note and Security Agreement dated as of September 12, 2025, by the Borrower in favor of the Lender (the “Agreement”), the Lender provided to the Borrower a term loan in an aggregate principal amount of up to $2.0 million (the “Term Loan”). As of the date of the First Amendment, the aggregate principal amount outstanding under the Term Loan was $2.0 million. The Agreement originally provided that the Term Loan would mature and terminate on the earlier of (i) the twelve (12) month anniversary of the Agreement, or (ii) the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Borrower from new equity investors (such date, the “Maturity Date”). The First Amendment, among other things, extends the Maturity Date described in clause (i) above to November 12, 2026, and provides that the sale of the Guarantor on the terms and conditions set forth in the First Amendment shall constitute a Permitted Disposition (as defined therein). Except as described above, all other material terms of the Agreement remain unchanged.

The foregoing descriptions of the Agreement, the First Amendment, and the transactions contemplated thereby are qualified in their entirety by reference to the full text of the Agreement, filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 17, 2025 and incorporated herein by reference, and the First Amendment, attached hereto as Exhibit 10.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
10.1		First Amendment to Secured Promissory Note and Security Agreement, dated as of September 12, 2026, by and among ChronoScale Intermediate, LLC (f/k/a Ekso Bionics Holdings, Inc.), as the borrower, Ekso Bionics, Inc., as guarantor, and B. Riley Commercial Capital, LLC, as lender.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		CHRONOSCALE HOLDINGS CORPORATION
Dated:	September 16, 2026	By:	/s/ Jerome Wong
		Name:	Jerome Wong
		Title:	Chief Financial Officer

Filing Exhibits & Attachments

4 documents

Agreements & Contracts

• EX-10.1 EX-10.1 29.2 KB

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB